drugset / Trial / NCT00056576

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

NCT00056576

Phase 3 Completed 165 enrolled Eisai Inc.
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether zonisamide alone is effective as a treatment for epilepsy in newly diagnosed cases.

Timeline

Start
2002-02
Primary completion
2004-10
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified